UA113991C2 - 1-(1-метил-1h-піразол-4-іл)-n-((1r,5s,7s)-9-метил-3-окса-9-азабіцикло[3.3.1]-нонан-7-іл)-1h-індол-3-карбоксамід як антагоніст 5-ht3 рецептора - Google Patents

1-(1-метил-1h-піразол-4-іл)-n-((1r,5s,7s)-9-метил-3-окса-9-азабіцикло[3.3.1]-нонан-7-іл)-1h-індол-3-карбоксамід як антагоніст 5-ht3 рецептора

Info

Publication number: UA113991C2
Authority: UA; Ukraine
Prior art keywords: methyl; nonan; azabicyclo; pyrazol; oxa
Prior art date: 2012-07-17

Application number

UAA201500605A

Other languages

English (en)

Ukrainian (uk)

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-07-17

Filing date

2013-07-16

Publication date

2017-04-10

2013-07-16 Application filed filed Critical

2013-07-16 Priority claimed from PCT/US2013/050746 external-priority patent/WO2014014951A1/fr

2017-04-10 Publication of UA113991C2 publication Critical patent/UA113991C2/uk

Links

-1 1-methyl-1H-pyrazol-4-yl Chemical group 0.000 title abstract 2
229940113081 5 Hydroxytryptamine 3 receptor antagonist Drugs 0.000 title 1
239000003369 serotonin 5-HT3 receptor antagonist Substances 0.000 title 1
150000001875 compounds Chemical class 0.000 abstract 2
206010013654 Drug abuse Diseases 0.000 abstract 1
208000018522 Gastrointestinal disease Diseases 0.000 abstract 1
208000002193 Pain Diseases 0.000 abstract 1
206010047700 Vomiting Diseases 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
210000001035 gastrointestinal tract Anatomy 0.000 abstract 1
208000015122 neurodegenerative disease Diseases 0.000 abstract 1
230000000626 neurodegenerative effect Effects 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
208000020016 psychiatric disease Diseases 0.000 abstract 1
239000002464 receptor antagonist Substances 0.000 abstract 1
229940044551 receptor antagonist Drugs 0.000 abstract 1
208000011117 substance-related disease Diseases 0.000 abstract 1
230000008673 vomiting Effects 0.000 abstract 1

Landscapes

Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

UAA201500605A 2012-07-17 2013-07-16 1-(1-метил-1h-піразол-4-іл)-n-((1r,5s,7s)-9-метил-3-окса-9-азабіцикло[3.3.1]-нонан-7-іл)-1h-індол-3-карбоксамід як антагоніст 5-ht3 рецептора UA113991C2 (xx)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US201261672709P	2012-07-17	2012-07-17
PCT/US2013/050746 WO2014014951A1 (fr)	2012-07-17	2013-07-16	Antagonistes du récepteur 5-ht3

Publications (1)

Publication Number	Publication Date
UA113991C2 true UA113991C2 (xx)	2017-04-10

Family

ID=58530739

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
UAA201500605A UA113991C2 (xx)	2012-07-17	2013-07-16	1-(1-метил-1h-піразол-4-іл)-n-((1r,5s,7s)-9-метил-3-окса-9-азабіцикло[3.3.1]-нонан-7-іл)-1h-індол-3-карбоксамід як антагоніст 5-ht3 рецептора

Country Status (2)

Country	Link
MA (1)	MA37836B1 (fr)
UA (1)	UA113991C2 (fr)

2013
- 2013-07-16 MA MA37836A patent/MA37836B1/fr unknown
- 2013-07-16 UA UAA201500605A patent/UA113991C2/uk unknown

Also Published As

Publication number	Publication date
MA37836A1 (fr)	2018-03-30
MA37836B1 (fr)	2018-10-31

Similar Documents

Publication	Publication Date	Title
EA201401150A1 (ru)	2015-04-30	Аминоиндолилзамещенные имидазолпиримидины и их применение в качестве лекарственных средств
SI2875011T1 (en)	2018-06-29	5-HT3 receptor antagonists
MX2013008431A (es)	2013-08-12	Antagonista del receptor de mineralocorticoides.
MY149731A (en)	2013-10-14	Compounds
BR112012017123A2 (pt)	2017-10-31	composto de n-(1h-indazol-4-il)imidazo [1,2-a]piridina-3-carboxamida como inibidores de cfms
TN2014000030A1 (en)	2015-07-01	Tetrahydropyrido-pyridine and tetrahydropyrido-pyrimidine compounds and use thereof as c5a receptor modulators
MD20150023A2 (ro)	2015-07-31	Piridinone biciclice noi
MX342161B (es)	2016-09-19	Compuestos antagonistas selectivos de receptor nk-3 novedosos, composicion farmaceutica y metodos para utilizarse en trastornos transmitidos por receptores nk-3.
EA201390977A1 (ru)	2013-12-30	Комбинация агониста опиоидных рецепторов и антагониста опиоидных рецепторов для лечения болезни паркинсона
EA201390969A1 (ru)	2013-12-30	Модуляторы глюкагонового рецептора
PH12013500007A1 (en)	2017-05-19	Piperidine derivatives and their use for the treatment of metabolic disorders
MX2014007897A (es)	2014-09-25	Nuevos derivados de azetidina, composiciones farmaceuticas y sus usos.
PH12014502586A1 (en)	2015-01-12	Novel ring-substituted n-pyridinyl amides as kinase inhibitors
EA201270428A1 (ru)	2012-08-30	Замещенные n-фенил-1-(4-пиридинил)-1н-пиразол-3-амины
MX353209B (es)	2018-01-08	Antagonistas d2, metodos de sintesis y metodos de uso.
BR112014001908A2 (pt)	2017-02-21	derivados aza heterocíclicos substituídos
PH12014501195A1 (en)	2014-09-01	Novel 2h-indazoles as ep2, receptor antagonists
TN2016000061A1 (en)	2017-07-05	Amide derivatives as lysophosphatidic acid receptor antagonists
UA117154C2 (uk)	2018-06-25	Антагоністи s1p3
MX2013006768A (es)	2013-07-22	Moduladores de receptor de glucagon.
PH12016501625A1 (en)	2016-11-07	Substituted cyclopentanes, tetrahydrofuranes and pyrrolidines as orexin receptor antagonists
WO2014014794A3 (fr)	2015-07-16	Antagonistes des récepteurs aux minéralocorticoïdes
EA201201530A1 (ru)	2013-07-30	Комбинация 4-{3-[цис-гексагидроциклопента[c]пиррол-2-(1h)-ил]пропокси} бензамида и антагониста nmda-рецептора и фармацевтические композиции, которые её содержат
MX354852B (es)	2018-03-22	Compuestos de heterociclilo comoligandos del receptor h3 de la histamina.
MX2014000855A (es)	2014-04-30	Moduladores receptores de glucagon de quinolinilo.